AXR-159

· AxeroVision, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXR-159, covering 2023-10-13 to 2023-10-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease [Phase 2]